Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

  1. Ocio, E.M.
  2. Perrot, A.
  3. Bories, P.
  4. San-Miguel, J.F.
  5. Blau, I.W.
  6. Karlin, L.
  7. Martinez-Lopez, J.
  8. Wang, S.-Y.
  9. Bringhen, S.
  10. Marcatti, M.
  11. Mateos, M.-V.
  12. Rodriguez-Otero, P.
  13. Oliva, S.
  14. Nogai, A.
  15. Le Roux, N.
  16. Dong, L.
  17. Macé, S.
  18. Gassiot, M.
  19. Fitzmaurice, T.
  20. Oprea, C.
  21. Moreau, P.
Journal:
Leukemia

ISSN: 1476-5551 0887-6924

Year of publication: 2023

Volume: 37

Issue: 7

Pages: 1521-1529

Type: Article

DOI: 10.1038/S41375-023-01936-7 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals